166 related articles for article (PubMed ID: 8598453)
1. Fas/Apo-1 (CD95) receptor lacking the intracytoplasmic signaling domain protects tumor cells from Fas-mediated apoptosis.
Cascino I; Papoff G; De Maria R; Testi R; Ruberti G
J Immunol; 1996 Jan; 156(1):13-7. PubMed ID: 8598453
[TBL] [Abstract][Full Text] [Related]
2. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.
Mitsiades N; Poulaki V; Tseleni-Balafouta S; Koutras DA; Stamenkovic I
Cancer Res; 2000 Aug; 60(15):4122-9. PubMed ID: 10945619
[TBL] [Abstract][Full Text] [Related]
3. Differential involvement of the CD95 (Fas/APO-1) receptor/ligand system on apoptosis induced by the wild-type p53 gene transfer in human cancer cells.
Fukazawa T; Fujiwara T; Morimoto Y; Shao J; Nishizaki M; Kadowaki Y; Hizuta A; Owen-Schaub LB; Roth JA; Tanaka N
Oncogene; 1999 Apr; 18(13):2189-99. PubMed ID: 10327065
[TBL] [Abstract][Full Text] [Related]
4. Agonist antibody and Fas ligand mediate different sensitivity to death in the signaling pathways of Fas and cytoplasmic mutants.
Thilenius AR; Braun K; Russell JH
Eur J Immunol; 1997 May; 27(5):1108-14. PubMed ID: 9174599
[TBL] [Abstract][Full Text] [Related]
5. Dendritic cells are resistant to apoptosis through the Fas (CD95/APO-1) pathway.
Ashany D; Savir A; Bhardwaj N; Elkon KB
J Immunol; 1999 Nov; 163(10):5303-11. PubMed ID: 10553053
[TBL] [Abstract][Full Text] [Related]
6. Stromal derived factor-1 alpha (SDF-1 alpha) induces CD4+ T cell apoptosis via the functional up-regulation of the Fas (CD95)/Fas ligand (CD95L) pathway.
Colamussi ML; Secchiero P; Gonelli A; Marchisio M; Zauli G; Capitani S
J Leukoc Biol; 2001 Feb; 69(2):263-70. PubMed ID: 11272277
[TBL] [Abstract][Full Text] [Related]
7. Segregation of APO-1/Fas antigen- and tumor necrosis factor receptor-mediated apoptosis.
Grell M; Krammer PH; Scheurich P
Eur J Immunol; 1994 Oct; 24(10):2563-6. PubMed ID: 7523147
[TBL] [Abstract][Full Text] [Related]
8. Human melanoma-reactive CD4+ and CD8+ CTL clones resist Fas ligand-induced apoptosis and use Fas/Fas ligand-independent mechanisms for tumor killing.
Rivoltini L; Radrizzani M; Accornero P; Squarcina P; Chiodoni C; Mazzocchi A; Castelli C; Tarsini P; Viggiano V; Belli F; Colombo MP; Parmiani G
J Immunol; 1998 Aug; 161(3):1220-30. PubMed ID: 9686582
[TBL] [Abstract][Full Text] [Related]
9. Fas/APO-1 gene transfer for human malignant glioma.
Weller M; Malipiero U; Rensing-Ehl A; Barr PJ; Fontana A
Cancer Res; 1995 Jul; 55(13):2936-44. PubMed ID: 7540953
[TBL] [Abstract][Full Text] [Related]
10. Glutamine deprivation-mediated cell shrinkage induces ligand-independent CD95 receptor signaling and apoptosis.
Fumarola C; Zerbini A; Guidotti GG
Cell Death Differ; 2001 Oct; 8(10):1004-13. PubMed ID: 11598798
[TBL] [Abstract][Full Text] [Related]
11. Induction of Fas expression and augmentation of Fas/Fas ligand-mediated apoptosis by the synthetic retinoid CD437 in human lung cancer cells.
Sun SY; Yue P; Hong WK; Lotan R
Cancer Res; 2000 Nov; 60(22):6537-43. PubMed ID: 11103825
[TBL] [Abstract][Full Text] [Related]
12. Activation of the Fas-FasL signaling pathway by MDA-7/IL-24 kills human ovarian cancer cells.
Gopalan B; Litvak A; Sharma S; Mhashilkar AM; Chada S; Ramesh R
Cancer Res; 2005 Apr; 65(8):3017-24. PubMed ID: 15833826
[TBL] [Abstract][Full Text] [Related]
13. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.
Xue C; Lan-Lan W; Bei C; Jie C; Wei-Hua F
Cell Immunol; 2006 Feb; 239(2):121-8. PubMed ID: 16808908
[TBL] [Abstract][Full Text] [Related]
14. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression.
Fulda S; Meyer E; Debatin KM
Cancer Res; 2000 Jul; 60(14):3947-56. PubMed ID: 10919673
[TBL] [Abstract][Full Text] [Related]
15. Fas signaling in thyroid carcinomas is diverted from apoptosis to proliferation.
Mitsiades CS; Poulaki V; Fanourakis G; Sozopoulos E; McMillin D; Wen Z; Voutsinas G; Tseleni-Balafouta S; Mitsiades N
Clin Cancer Res; 2006 Jun; 12(12):3705-12. PubMed ID: 16778096
[TBL] [Abstract][Full Text] [Related]
16. Resistance to Fas-mediated apoptosis in human hepatoma cells.
Natoli G; Ianni A; Costanzo A; De Petrillo G; Ilari I; Chirillo P; Balsano C; Levrero M
Oncogene; 1995 Sep; 11(6):1157-64. PubMed ID: 7566976
[TBL] [Abstract][Full Text] [Related]
17. Frequent deletion of Fas gene sequences encoding death and transmembrane domains in nasal natural killer/T-cell lymphoma.
Shen L; Liang AC; Lu L; Au WY; Kwong YL; Liang RH; Srivastava G
Am J Pathol; 2002 Dec; 161(6):2123-31. PubMed ID: 12466128
[TBL] [Abstract][Full Text] [Related]
18. Ligation of CD40 potentiates Fas-mediated activation of the cysteine protease CPP32, cleavage of its death substrate PARP, and apoptosis in Ramos-Burkitt lymphoma B cells.
An S; Yap D; Knox KA
Cell Immunol; 1997 Nov; 181(2):139-52. PubMed ID: 9398401
[TBL] [Abstract][Full Text] [Related]
19. FK506 restores sensitivity of thymic lymphomas to calcium-mediated apoptosis and the inducible expression of Fas ligand.
Kalas W; Matuszyk J; Ziolo E; Strzadala L
Anticancer Res; 2003; 23(2B):1613-7. PubMed ID: 12820430
[TBL] [Abstract][Full Text] [Related]
20. Chromosome 22 complements apoptosis in Fas-and TNF-resistant mutant UK110 cells.
Noguchi K; Naito M; Oshimura M; Mashima T; Fujita N; Yonehara S; Tsuruo T
Oncogene; 1996 Jul; 13(1):39-46. PubMed ID: 8700552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
